Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

By J. Pignon, J. Bourhis, Christian Domenge, L. Designé, O. B. O. C. C. Group. The Lancet, 2000

2,306 citations recorded by the source corpus.

Summary Background Despite more than 70 randomised trials, the effect of chemotherapy on non-metastatic head and neck squamous-cell carcinoma remains uncertain. We did three meta-analyses of the impact of survival on chemotherapy added to locoregional treatment. Methods We updated data on all patients in randomised trials between 1965 and 1993. We included patients with carcinoma of the oropharynx, oral cavity, larynx, or hypopharynx. Findings The main meta-analysis of 63 trials (10 741 patients) of locoregional treatment with or without chemotherapy yielded a pooled hazard ratio of death of 0·90 (95% CI 0·85–0·94, p Interpretation Because the main meta-analysis showed only a small significant survival benefit in favour of chemotherapy, the routine use of chemotherapy is debatable. For larynx preservation, the non-significant negative effect of chemotherapy in the organ-preservation strategy indicates that this procedure must remain investigational.

Subfields: Otorhinolaryngology, Surgery

View Paper: https://www.semanticscholar.org/paper/bd152c143872bdbdbc84901d6de39a1eeda2a602

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Otorhinolaryngology

  1. J. Bourhis
  2. Jean-Pierre Pignon

In Surgery

  1. E. Maillard
  2. A. le Maître
  3. J. Bourhis
  4. Jean-Pierre Pignon

Citations in the corpus